Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers (Q28141250)

1

0 references

Y Maehara

2

0 references

E Oki

3

0 references

K Kitamura

4

0 references

Y Kakeji

5

0 references

S Ohno

6

0 references

K Sugimachi

Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation

7

0 references

language of work or name

English

0 references

publication date

28 April 2000

0 references

published in

Cancer Letters

0 references

volume

152

0 references

issue

1

0 references

page(s)

15-22

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

Tumourigenesis associated with the p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

Mdm-2: "big brother" of p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

From bench top to bedside

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

Tumor suppressors. Teaming up to restrain cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

Real time quantitative PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900434-6

7 January 2021

10.1016/S0304-3835(99)00434-6

Identifiers

DOI

0 references

Fatcat ID

release_eeyhicplujdufjv7kl7ae2tvii

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eeyhicplujdufjv7kl7ae2tvii

24 November 2022